PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Phenylbutyrate→

Phenylbutyrate PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
1821-12-1
Molecular formula
C10H12O2
Molecular weight
164.2 g/mol
Drug class
Ammonia-scavenging nitrogen-binding agenttreatment for urea-cycle disorders
Mechanism of action
Phenylbutyrate is metabolised to phenylacetate, which conjugates with glutamine to form phenylacetylglutamine. This nitrogen-containing conjugate is excreted in urine, providing an alternative pathway for waste-nitrogen removal and lowering plasma ammonia.
Indications / reported uses
  • Adjunctive chronic management of patients with urea-cycle disorders involving deficiencies of carbamoyl phosphate synthetase, ornithine transcarbamylase or argininosuccinate synthetase, in conjunction with dietary management and other indicated therapy.

Sources: https://www.dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=d08fd548-7eb8-4f6f-b664-b0fff6f30065&type=display · https://pmc.ncbi.nlm.nih.gov/articles/PMC3488504/ · DailyMed

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Phenylbutyrate PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Phenylbutyrate Permitted Daily Exposure (PDE) report (the Phenylbutyrate PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Phenylbutyrate Occupational Exposure Limit (OEL) report (the Phenylbutyrate OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.